BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20529825)

  • 41. CXCR3, CXCR5, CXCR6, and CXCR7 in Diabetes.
    Fallahi P; Corrado A; Di Domenicantonio A; Frenzilli G; Antonelli A; Ferrari SM
    Curr Drug Targets; 2016; 17(5):515-9. PubMed ID: 25547908
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proinflammatory CXCL12-CXCR4/CXCR7 Signaling Axis Drives Myc-Induced Prostate Cancer in Obese Mice.
    Saha A; Ahn S; Blando J; Su F; Kolonin MG; DiGiovanni J
    Cancer Res; 2017 Sep; 77(18):5158-5168. PubMed ID: 28687617
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lipopolysaccharide Promotes Choroidal Neovascularization by Up-Regulation of CXCR4 and CXCR7 Expression in Choroid Endothelial Cell.
    Feng YF; Guo H; Yuan F; Shen MQ
    PLoS One; 2015; 10(8):e0136175. PubMed ID: 26288180
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cancer cell-derived lymphotoxin mediates reciprocal tumour-stromal interactions in human ovarian cancer by inducing CXCL11 in fibroblasts.
    Lau TS; Chung TK; Cheung TH; Chan LK; Cheung LW; Yim SF; Siu NS; Lo KW; Yu MM; Kulbe H; Balkwill FR; Kwong J
    J Pathol; 2014 Jan; 232(1):43-56. PubMed ID: 24014111
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Close correlation between CXCR4 and VEGF expression and frequent CXCR7 expression in rhabdomyosarcoma.
    Miyoshi K; Kohashi K; Fushimi F; Yamamoto H; Kishimoto J; Taguchi T; Iwamoto Y; Oda Y
    Hum Pathol; 2014 Sep; 45(9):1900-9. PubMed ID: 25086956
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer.
    Zhang C; Li Z; Xu L; Che X; Wen T; Fan Y; Li C; Wang S; Cheng Y; Wang X; Qu X; Liu Y
    BMC Cancer; 2018 Apr; 18(1):462. PubMed ID: 29690901
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Llama-derived single variable domains (nanobodies) directed against chemokine receptor CXCR7 reduce head and neck cancer cell growth in vivo.
    Maussang D; Mujić-Delić A; Descamps FJ; Stortelers C; Vanlandschoot P; Stigter-van Walsum M; Vischer HF; van Roy M; Vosjan M; Gonzalez-Pajuelo M; van Dongen GA; Merchiers P; van Rompaey P; Smit MJ
    J Biol Chem; 2013 Oct; 288(41):29562-72. PubMed ID: 23979133
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CXCL11-CXCR3 Axis Mediates Tumor Lymphatic Cross Talk and Inflammation-Induced Tumor, Promoting Pathways in Head and Neck Cancers.
    Kumaravel S; Singh S; Roy S; Venkatasamy L; White TK; Sinha S; Glaser SS; Safe SH; Chakraborty S
    Am J Pathol; 2020 Apr; 190(4):900-915. PubMed ID: 32035061
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of MicroRNA-218 on the viability, apoptosis and invasion of renal cell carcinoma cells under hypoxia by targeted downregulation of CXCR7 expression.
    Zhang S; Hong Z; Li Q; Lei J; Huang H; Liu Q
    Biomed Pharmacother; 2016 May; 80():213-219. PubMed ID: 27133059
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stem cells migration during skeletal muscle regeneration - the role of Sdf-1/Cxcr4 and Sdf-1/Cxcr7 axis.
    Kowalski K; Kołodziejczyk A; Sikorska M; Płaczkiewicz J; Cichosz P; Kowalewska M; Stremińska W; Jańczyk-Ilach K; Koblowska M; Fogtman A; Iwanicka-Nowicka R; Ciemerych MA; Brzoska E
    Cell Adh Migr; 2017 Jul; 11(4):384-398. PubMed ID: 27736296
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CXCL12 receptor preference, signal transduction, biological response and the expression of 5T4 oncofoetal glycoprotein.
    McGinn OJ; Marinov G; Sawan S; Stern PL
    J Cell Sci; 2012 Nov; 125(Pt 22):5467-78. PubMed ID: 22956548
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modulatory effects of trophoblast-secreted CXCL12 on the migration and invasion of human first-trimester decidual epithelial cells are mediated by CXCR4 rather than CXCR7.
    Zheng J; Wang H; Zhou W
    Reprod Biol Endocrinol; 2018 Mar; 16(1):17. PubMed ID: 29499763
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Knockdown of CXCR7 inhibits proliferation and invasion of osteosarcoma cells through inhibition of the PI3K/Akt and β-arrestin pathways.
    Zhang Y; Yang CQ; Gao Y; Wang C; Zhang CL; Zhou XH
    Oncol Rep; 2014 Sep; 32(3):965-72. PubMed ID: 24969680
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of CXCR4 and CXCR7 for reduction of cell proliferation and invasion in human endometrial cancer.
    Long P; Sun F; Ma Y; Huang Y
    Tumour Biol; 2016 Jun; 37(6):7473-80. PubMed ID: 26678890
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expressions of CXCR7/ligands may be involved in oral carcinogenesis.
    Xia J; Wang J; Chen N; Dai Y; Hong Y; Chen X; Cheng B
    J Mol Histol; 2011 Apr; 42(2):175-80. PubMed ID: 21442287
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CXCL12-CXCR7 axis is important for tumor endothelial cell angiogenic property.
    Yamada K; Maishi N; Akiyama K; Towfik Alam M; Ohga N; Kawamoto T; Shindoh M; Takahashi N; Kamiyama T; Hida Y; Taketomi A; Hida K
    Int J Cancer; 2015 Dec; 137(12):2825-36. PubMed ID: 26100110
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CXCR7 mediates SDF1-induced melanocyte migration.
    Lee E; Han J; Kim K; Choi H; Cho EG; Lee TR
    Pigment Cell Melanoma Res; 2013 Jan; 26(1):58-66. PubMed ID: 22978759
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CXCR4 and CXCR7 Mediate TFF3-Induced Cell Migration Independently From the ERK1/2 Signaling Pathway.
    Dieckow J; Brandt W; Hattermann K; Schob S; Schulze U; Mentlein R; Ackermann P; Sel S; Paulsen FP
    Invest Ophthalmol Vis Sci; 2016 Jan; 57(1):56-65. PubMed ID: 26780310
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.
    Nazari A; Khorramdelazad H; Hassanshahi G
    Int J Clin Oncol; 2017 Dec; 22(6):991-1000. PubMed ID: 29022185
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma.
    Suyama T; Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ichikawa T; Ueda T; Nikaido T; Ito H; Ishikura H
    Cancer; 2005 Jan; 103(2):258-67. PubMed ID: 15578685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.